查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1417405

心臟衰竭POC/LOC 設備的全球市場：趨勢、預測與競爭分析（~2030 年）

Heart Failure POC & LOC Device Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到2030年，全球心臟衰竭POC/LOC設備市場規模將達到約3億美元，2024年至2030年年複合成長率為15.9%。心臟衰竭POC/LOC 設備市場的未來看起來充滿希望，診所、醫院、家庭、輔助生活設施和實驗室市場都有機會。該市場的主要促進因素是小型化、實驗室晶片技術，該技術在提高疾病診斷方面的成本效率、通量、易操作性、分析和心血管疾病診斷方面顯示出巨大潛力。致力於創建基於實驗室晶片技術的創新檢測方法。

心臟衰竭POC/LOC 設備市場洞察

Lucintel 預測，由於人們對心血管疾病死亡率和發病率的擔憂不斷增加，微流體在預測期內仍將是最大的細分市場。

這是因為門診診所擴大大規模採用照護現場設備，以實現及時、準確的診斷，並為心臟衰竭做出明智的治療決策。

在預測期內，北美可能仍然是最大的地區，因為美國市場的主要企業對全球心臟衰竭領域的顯著有機收益成長做出了重大貢獻。

常問問題

Q1.市場規模有多大？

A1. 到 2030 年，全球心臟衰竭POC/LOC 設備市場預計將達到 3 億美元。

Q2.市場成長預測如何？

A2. 預計 2024 年至 2030 年，全球心臟衰竭POC/LOC 設備市場將以 15.9% 的年複合成長率成長。

Q3.影響市場成長的主要促進因素有哪些？

A3. 該市場的主要驅動力是小型化，實驗室晶片技術在成本效率、通量、操作簡便性和分析方面顯示出增強疾病診斷的巨大潛力，從而改善心血管疾病的診斷。目前正在開發基於實驗室晶片技術的創新檢測方法。

Q4.市場的主要細分市場是什麼？

A4.心臟衰竭POC/LOC 設備市場的未來看起來充滿希望，診所、醫院、家庭、輔助生活醫療機構和實驗室市場都有機會。

Q5.市場上主要企業有哪些？

A5. 生產心臟衰竭POC/LOC 設備的一些主要企業如下。

  • Abbott
  • Danahar
  • Siemens Healthineers
  • F. Hoffmann-La Roche
  • Quidel
  • bioMerieux
  • Trinity BiotechInstrumentation

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預測，由於人們對心血管疾病死亡率和發病率的擔憂日益增加，微流體在預測期內仍將是最大的細分市場。

Q7. 未來五年預計哪個地區將成為最大的市場？

A7. 預計北美在預測期內仍將是最大的地區，因為美國市場的主要企業對全球心臟衰竭領域的顯著有機收益成長做出了重大貢獻。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球心臟衰竭POC/LOC 設備市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢與預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球心臟衰竭POC/LOC設備市場趨勢（2018-2023）與預測（2024-2030）
  • 全球心臟衰竭POC/LOC 設備市場：依技術分類
    • 微流體
    • 基於陣列的系統
    • 其他
  • 全球心臟衰竭POC/LOC 設備市場：依測試類型
    • 蛋白質體學測試
    • 代謝組測試
    • 基因組測試
  • 全球心臟衰竭POC/LOC 設備市場：依最終用途產業分類
    • 診所
    • 醫院
    • 家
    • 生活支援醫療設施
    • 研究員
    • 其他

第4章市場趨勢與預測分析：按地區（2018-2030）

  • 按地區分類的全球心臟衰竭POC/LOC 設備市場
  • 北美洲
  • 歐洲
  • 亞太地區
  • 其他地區

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 依技術
    • 按測試類型
    • 按最終用途行業
    • 按地區
  • 全球心臟衰竭POC/LOC器材市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球心臟衰竭POC/LOC設備市場產能
    • 全球心臟衰竭POC/LOC設備市場的併購和合資企業
    • 認證和許可

第7章主要企業概況

  • Abbott
  • Danahar
  • Siemens Healthineers
  • F. Hoffmann-La Roche
  • Quidel
  • bioMerieux
  • Trinity BiotechInstrumentation
簡介目錄

Heart Failure POC & LOC Device Trends and Forecast

The future of the heart failure POC & LOC device market looks promising with opportunities in the clinics, hospitals, homes, assisted living healthcare facilities, and laboratories markets. The heart failure POC & LOC device market is expected to reach an estimated $0.3 billion by 2030 with a CAGR of 15.9% from 2024 to 2030. The major drivers for this market are miniaturization, lab-on-chip technology shows significant potential for enhancing disease diagnosis in terms of cost-efficiency, throughput, simplicity of operation, and analysis and research and development efforts directed at creating innovative assays based on lab-on-chip technology for cardiovascular disease diagnosis.

A more than 150-page report is developed to help in your business decisions.

Heart Failure POC & LOC Device by Segment

The study includes a forecast for the global heart failure POC & LOC device by technology, test type, end use industry, and region.

Heart Failure POC & LOC Device Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Microfluidics
  • Array-Based Systems
  • Others

Heart Failure POC & LOC Device Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

  • Proteomic Testing
  • Metabolomic Testing
  • Genomic Testing

Heart Failure POC & LOC Device Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Clinics
  • Hospitals
  • Home
  • Assisted Living Healthcare Facilities
  • Laborator
  • Others

Heart Failure POC & LOC Device Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Heart Failure POC & LOC Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies heart failure POC & LOC device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the heart failure POC & LOC device companies profiled in this report include-

  • Abbott
  • Danahar
  • Siemens Healthineers
  • F. Hoffmann-La Roche
  • Quidel
  • bioMerieux
  • Trinity BiotechInstrumentation

Heart Failure POC & LOC Device Market Insights

Lucintel forecasts that microfluidics will remain the largest segment over the forecast period due to increasing worry regarding mortality and morbidity rates stemming from cardiovascular diseases.

Within this market, clinic will remain the largest segment due to outpatient clinics are increasingly employing point-of-care devices on a larger scale to achieve timely and accurate diagnoses, enabling well-informed treatment decisions for heart failure.

North America will remain the largest region over the forecast period due to major key players in the u.s. market are significantly contributing to substantial organic revenue growth in the global heart failure sector.

Features of the Heart Failure POC & LOC Device Market

Market Size Estimates: Heart failure POC & LOC device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Heart failure POC & LOC device market size by technology, test type, end use industry, and region in terms of value ($B).

Regional Analysis: Heart failure POC & LOC device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technology, test type, end use industry, and regions for the heart failure POC & LOC device market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the heart failure POC & LOC device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the heart failure POC & LOC device market size?

Answer: The global heart failure POC & LOC device market is expected to reach an estimated $0.3 billion by 2030.

Q2. What is the growth forecast for heart failure POC & LOC device market?

Answer: The global heart failure POC & LOC device market is expected to grow with a CAGR of 15.9% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the heart failure POC & LOC device market?

Answer: The major drivers for this market are miniaturization, lab-on-chip technology shows significant potential for enhancing disease diagnosis in terms of cost-efficiency, throughput, simplicity of operation, and analysis and research and development efforts directed at creating innovative assays based on lab-on-chip technology for cardiovascular disease diagnosis.

Q4. What are the major segments for heart failure POC & LOC device market?

Answer: The future of the heart failure POC & LOC device market looks promising with opportunities in the clinics, hospitals, homes, assisted living healthcare facilities, and laboratories markets.

Q5. Who are the key heart failure POC & LOC device market companies?

Answer: Some of the key heart failure POC & LOC device companies are as follows.

  • Abbott
  • Danahar
  • Siemens Healthineers
  • F. Hoffmann-La Roche
  • Quidel
  • bioMerieux
  • Trinity BiotechInstrumentation

Q6. Which heart failure POC & LOC device market segment will be the largest in future?

Answer: Lucintel forecasts that microfluidics will remain the largest segment over the forecast period due to increasing worry regarding mortality and morbidity rates stemming from cardiovascular diseases.

Q7. In heart failure POC & LOC device market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to major key players in the u.s. market are significantly contributing to substantial organic revenue growth in the global heart failure sector.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the heart failure POC & LOC device market by technology (microfluidics, array-based systems, and others), test type (proteomic testing, metabolomic testing, and genomic testing), end use industry (clinics, hospitals, home, assisted living healthcare facilities, laborator, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Heart Failure POC & LOC Device Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Heart Failure POC & LOC Device Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Heart Failure POC & LOC Device Market by Technology
    • 3.3.1: Microfluidics
    • 3.3.2: Array-Based Systems
    • 3.3.3: Others
  • 3.4: Global Heart Failure POC & LOC Device Market by Test Type
    • 3.4.1: Proteomic Testing
    • 3.4.2: Metabolomic Testing
    • 3.4.3: Genomic Testing
  • 3.5: Global Heart Failure POC & LOC Device Market by End Use Industry
    • 3.5.1: Clinics
    • 3.5.2: Hospitals
    • 3.5.3: Home
    • 3.5.4: Assisted Living Healthcare Facilities
    • 3.5.5: Laborator
    • 3.5.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Heart Failure POC & LOC Device Market by Region
  • 4.2: North American Heart Failure POC & LOC Device Market
    • 4.2.2: North American Heart Failure POC & LOC Device Market by End Use Industry: Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laborator, and Others
  • 4.3: European Heart Failure POC & LOC Device Market
    • 4.3.1: European Heart Failure POC & LOC Device Market by Technology: Microfluidics, Array-Based Systems, and Others
    • 4.3.2: European Heart Failure POC & LOC Device Market by End Use Industry: Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laborator, and Others
  • 4.4: APAC Heart Failure POC & LOC Device Market
    • 4.4.1: APAC Heart Failure POC & LOC Device Market by Technology: Microfluidics, Array-Based Systems, and Others
    • 4.4.2: APAC Heart Failure POC & LOC Device Market by End Use Industry: Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laborator, and Others
  • 4.5: ROW Heart Failure POC & LOC Device Market
    • 4.5.1: ROW Heart Failure POC & LOC Device Market by Technology: Microfluidics, Array-Based Systems, and Others
    • 4.5.2: ROW Heart Failure POC & LOC Device Market by End Use Industry: Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laborator, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Heart Failure POC & LOC Device Market by Technology
    • 6.1.2: Growth Opportunities for the Global Heart Failure POC & LOC Device Market by Test Type
    • 6.1.3: Growth Opportunities for the Global Heart Failure POC & LOC Device Market by End Use Industry
    • 6.1.4: Growth Opportunities for the Global Heart Failure POC & LOC Device Market by Region
  • 6.2: Emerging Trends in the Global Heart Failure POC & LOC Device Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Heart Failure POC & LOC Device Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Heart Failure POC & LOC Device Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott
  • 7.2: Danahar
  • 7.3: Siemens Healthineers
  • 7.4: F. Hoffmann-La Roche
  • 7.5: Quidel
  • 7.6: bioMerieux
  • 7.7: Trinity BiotechInstrumentation